Immunovant, Inc. (IMVT) SEC Filings https://www.immunovant.com/investors/sec-filings/all-sec-filings/rss Immunovant, Inc. (IMVT) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_d6ae8ad1fc90c30ceeec0c8ff3e3b1be/immunovant/files/theme/images/logo-sm.jpg Immunovant, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000067/0001764013-26-000067.pdf Fri, 22 May 26 16:04:07 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000067/0001764013-26-000067.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001643071-26-000004/0001643071-26-000004.pdf Wed, 20 May 26 21:22:22 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001643071-26-000004/0001643071-26-000004.pdf <![CDATA[144 - Report of proposed sale of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-004841/0001950047-26-004841.pdf Wed, 20 May 26 16:38:25 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-004841/0001950047-26-004841.pdf <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf Wed, 20 May 26 07:28:40 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000064/0001764013-26-000064.pdf <![CDATA[8-K - Current report]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000062/0001764013-26-000062.pdf Wed, 20 May 26 07:14:27 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000062/0001764013-26-000062.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000058/0001764013-26-000058.pdf Fri, 01 May 26 18:40:44 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000058/0001764013-26-000058.pdf <![CDATA[144 - Report of proposed sale of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-003928/0001950047-26-003928.pdf Fri, 01 May 26 16:46:45 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001950047-26-003928/0001950047-26-003928.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000056/0001764013-26-000056.pdf Fri, 24 Apr 26 16:07:51 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000056/0001764013-26-000056.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000055/0001764013-26-000055.pdf Fri, 24 Apr 26 16:07:06 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001764013-26-000055/0001764013-26-000055.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001779707-26-000004/0001779707-26-000004.pdf Fri, 10 Apr 26 16:06:46 -0400 https://www.immunovant.com/investors/sec-filings/all-sec-filings/content/0001779707-26-000004/0001779707-26-000004.pdf